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Through yeast two-hybrid analysis and coimmunoprecipitation studies, we have identified a novel cellular AAV-2 Rep78/Rep68 interaction
partner located predominantly in the cytoplasm. In public databases, it has been assigned as KCTD5, because of a region of high similarity to the
cytoplasmic tetramerization domain of voltage-gated potassium channels. Whereas Rep/KCTD5 interaction relied on the region surrounding the
Rep nuclear localization signal, nuclear accumulation of Rep was not required. Wildtype Rep78/Rep68 proteins induced the translocation of large
portions of KCTD5 into the nucleus pointing to functional interactions both in the cytoplasm and the nucleus. In line with an anticipated functional
interference in the cytoplasm, KCTD5 overexpression completely abrogated Rep68-mediated posttranscriptional activation of a HIV-LTR driven
luciferase reporter gene. Our study expands the panel of already identified nuclear Rep interaction partners to a cytoplasmic protein, which raises
the awareness that important steps in the AAV life cycle may be regulated in this compartment.
© 2006 Elsevier Inc. All rights reserved.Keywords: AAV; Rep proteins; KCTD5; Tetramerization domainIntroduction
Adeno-associated virus type 2 (AAV-2) is a human parvo-
virus of the Dependovirus genus that relies on a coinfecting
helpervirus such as adenovirus (Atchison et al., 1965) or herpes
simplex virus (Buller et al., 1981) for productive replication
(Berns and Linden, 1995). Whereas a low level of helper-
independent DNA replication can be detected in cells exposed
to genotoxic agents (Yakobson et al., 1989; Yakobson et al.,
1987; Yalkinoglu et al., 1988), infection in the absence of a
helpervirus usually results in a latent state of AAV-2 by site-
specific integration of the viral DNA into human chromosome
19 (Samulski, 1993). The integrated provirus can then be
reactivated by superinfection with a helpervirus (Berns and
Linden, 1995).Abbreviations: AAV-2, adeno-associated virus type 2; NLS, nuclear
localization signal; ITR, inverted terminal repeat; TD, tetramerization domain.
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doi:10.1016/j.virol.2006.12.010The 4.7-kb single-stranded AAV-2 DNA genome (Srivastava
et al., 1983) encompasses two major open reading frames,
termed rep and cap, flanked by two 145 base pair inverted
terminal repeats (ITRs). As essential cis-acting elements the
ITRs are required as origins for AAV DNA replication, as AAV
packaging signals, as well as for AAV integration into the host
cell genome. Whereas cap encodes the three structural proteins,
VP1, VP2 and VP3 (Becerra et al., 1988; Cassinotti et al., 1988)
expressed from a promoter located at map position 40 (p40), rep
encodes four overlapping regulatory (Rep) proteins (Mendelson
et al., 1986). The large Rep proteins Rep78 and Rep68 are the
translation products of unspliced and single-spliced mRNAs,
respectively, which are transcribed from the p5 promoter. They
are essential for AAV-2 DNA replication and regulation of AAV
gene expression in the presence of a helpervirus (Hermonat et
al., 1984; Tratschin et al., 1984) as well as for site-specific
integration in the absence of helpervirus (Balague et al., 1997;
Samulski, 1993; Weitzman et al., 1994). Both functions involve
ATP-dependent helicase, site- and strand-specific endonuclease
and sequence-specific DNA binding activities of Rep78 and
Rep68 (Im and Muzyczka, 1990, 1992). The small Rep proteins
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represent N-terminally truncated versions of the large Rep
proteins, which lack the first 224 Rep amino acids involved in
site-specific DNA binding (Owens et al., 1993). They mediate
the translocation of the single-stranded AAV progeny DNA into
the preformed capsid (King et al., 2001), a process, which ap-
pears to involve complex formation with the large Rep proteins
(Dubielzig et al., 1999).
The large Rep proteins Rep78/Rep68 also display a variety
of activities not immediately related to the AAV-2 life cycle.
They inhibit human immunodeficiency virus (HIV) type1
production in human cells, most probably through suppression
of transcription from the HIV long terminal repeat (LTR)
control region (Antoni et al., 1991; Horer et al., 1995).
Furthermore, they also affect the expression of various other
cellular and viral genes as detected by reporter gene assays
(Hermonat, 1994; Horer et al., 1995; Labow et al., 1987). In
most of these cases, it has not been determined, whether
inhibition takes place at the transcriptional or posttranscrip-
tional level. For a luciferase reporter gene driven by the human
cytomegalovirus immediate-early promoter, Rep78-mediated
inhibition of luciferase activity was reported in the presence of
increased levels of luciferase mRNA (Takeuchi et al., 2000). In
the same study, Rep78/Rep68 have also been demonstrated to
suppress translation of luciferase mRNA in vitro.
In cell fractionation experiments and immunofluorescence
analysis, the Rep78/Rep68 proteins are detected mainly in the
nucleus (Hunter and Samulski, 1992; Im and Muzyczka, 1992;
Wistuba et al., 1995), whereas the small Rep proteins Rep52/
Rep40 are also found in the cytoplasm. However, Rep68 has
also been purified from the cytoplasmic fraction of HeLa cells
coinfected with AAV-2 and adenovirus (Im and Muzyczka,
1990). The Rep proteins have been shown to bind to a variety of
nuclear proteins. Rep78/Rep68-mediated activation of p19 and
p40 gene expression in the presence of adenovirus involves
interaction with transcription factor Sp1 (Pereira andMuzyczka,
1997b). Through their C-terminal domains, Rep78 and Rep52
interact with and inhibit cAMP-dependent protein kinase A
(PKA) and its homolog PrKX (Chiorini et al., 1998). Other
direct cellular interaction partners of the Rep proteins include
the high mobility chromosomal protein HMG1 (Costello et al.,
1997), the TATA box binding protein TBP (Hermonat et al.,
1998), the tumor suppressor protein p53 (Batchu et al., 1999),
the transcriptional coactivator PC4 (Weger et al., 1999) and the
topoisomerase I binding RS-rich protein Topors (Weger et al.,
2002).
The C-terminus of Rep78/Rep68 contains two stretches of
basic amino acids with close similarity to the bipartite nuclear
localization signal found in nucleoplasmin and other nuclear
proteins (Robbins et al., 1991). Either deletion of this region
(Yang et al., 1992) or point mutations of the basic residues
(Cassell and Weitzman, 2004) generate Rep proteins, which are
located predominantly in the cytoplasm of transfected cells.
Rep78/Rep68 have been shown to bind to the α nuclear import
receptor (importin α) in vitro through this region (Cassell and
Weitzman, 2004). Surprisingly, Rep78 harboring the point
mutations was only slightly compromised for promotion ofAAV DNA replication (Cassell and Weitzman, 2004). This led
to the suggestion that the Rep proteins may be capable of shut-
tling between cellular compartments (Cassell and Weitzman,
2004). Nothing is known yet about cellular factors, which
mediate nuclear trafficking of Rep or vice versa, and the
consequences thereof for the regulation of the AAV life cycle.
In the present study, we have identified an interaction partner
of the large Rep proteins, whose subcellular distribution is
significantly altered by Rep expression. The protein was named
KCTD5, based on a homology region with the cytoplasmic
tetramerization domain (T1) of voltage-gated potassium chan-
nels. KCTD5 interacts with Rep78/Rep 68 both in the yeast
two-hybrid system and in coprecipitation studies in mammalian
cells. Through complex formation presumably in the cytoplasm,
Rep78/Rep68 induces the translocation of KCTD5 into the
nucleus. In addition, KCTD5 abrogates Rep68-mediated
posttranscriptional activation of a HIV-LTR driven reporter
gene.
Results
Identification of a cDNA encoding a Rep68 interacting cellular
protein
We have already reported on the identification of several
cellular interaction partners of the large AAV-2 Rep protein
Rep68 by means of yeast based two-hybrid screens of a HeLa
cDNA target library (Weger et al., 2002, 2004, 1999). The most
frequent interaction partner observed in these screens was the
transcriptional coactivator PC4. When we repeated these
experiments with a target library from 293 cells, we obtained
11 positive clones, which did not correspond to PC4 or the other
Rep interaction partners identified before in HeLa cells. They all
had a size of about 2.4 kb and produced identical fragmentation
patterns upon digestion with a variety of restriction enzymes.
The cDNA inserts of three selected clones were sequenced and
found to contain essentially the same sequence information.
Two of the clones harbored an open reading frame (ORF) of 234
amino acids with an ATG start codon embedded in a sequence
closely matching the Kozak consensus sequence (Fig. 1A). The
cDNA insert of the third clone started at amino acid 21 of this
open reading frame. Several almost identical nucleic acid
sequences have already been deposited in public databases
(with GenBank accession no. BC007314 representing the best
match identified). They all predicted an ORF of 234 amino
acids. The corresponding polypeptide (GenBank accession no.
AAH07314, with one amino acid exchange as compared to our
sequence) has been assigned as potassium channel tetrameriza-
tion domain containing 5 (KCTD5), because the region located
between amino acids 45 and 135 displays strong similarity to
the N-terminal, cytoplasmic tetramerization domain (T1) of
voltage-gated K+ channels (Fig. 1B). This domain is also
distantly related to the BTB/POZ domain found as protein–
protein interaction motif at the N-terminus of several C2H2-
type transcription factors. However, the similarities to these
proteins are limited to this region. In the following, we will refer
to the identified Rep68 interaction partner as KCTD5.
Fig. 1. (A) Nucleotide sequence of the isolated cDNA encoding the KCTD5 protein. The deduced sequence of the 234 amino acid open reading frame is given below
the nucleotide sequence. The region displaying high similarity to the cytoplasmic tetramerization domain (T1) of voltage-gated potassium channels is indicated in
white letters on a black background. (B) Alignment of KCTD5 amino acids 45 to 135 with the T1 domain of voltage-gated K+ channels. Residues identical in both
proteins are indicated in white letters.
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of both proteins in the yeast two-hybrid system
Several deletion mutants were generated for both Rep and
the KCTD5 polypeptide to map the domains involved in the
yeast two-hybrid interaction. Deletion of the DNA binding
domain located in the N-terminus of Rep68 abolished inter-
action with KCTD5 (Fig. 2B, M172/530 and Rep40). Whereasthe C-terminal amino acids of Rep68 downstream of amino acid
515 could be deleted without a significant decrease in the
strength of interaction, the region between amino acids 482 and
514, which harbors the Rep nuclear localization signal (NLS),
was absolutely required (Fig. 2B, compare M1/514 with M1/
481). Based on the previously documented two-hybrid interac-
tion of M172/530 and M1/481 with other Rep interaction
partners (Weger et al., 2004, 1999), we rather exclude the
Fig. 2. Yeast two-hybrid interaction of Rep68 with KCTD5. (A) Schematic representation of the AAV-2 genome and the two Rep proteins Rep68 and Rep40 translated
from the spliced p5 and p19 mRNAs. The inverted terminal repeats (ITR's) are represented by hatched boxes, the three promoters at map units 5, 19 and 40 are
indicated by right-angled arrows and the common polyadenylation (polyA) site for all transcripts at map position 96 is indicated by the vertical arrow. Differently
shaded boxes indicate the N-terminal DNA-binding domain of the large Rep proteins, the central region common to all 4 Rep proteins and the Rep68/Rep40-specific 7
C-terminal amino acids. The closed box represents the region harboring the nuclear localization signal (NLS). Characteristic amino acid positions are given above the
boxes. (B) Analysis of Rep domains required for interaction with full-length KCTD5 in the yeast two-hybrid system. The Rep regions fused to the Gal4 DNA binding
domain are shown schematically on the left and indicated by amino acid numbers. The respective reporter β-galactosidase (β-gal) activities expressed in Units are
shown on the right. (C) Analysis of KCTD5 domains required for interaction with Rep68 in the yeast two-hybrid system. The KCTD5 regions fused to the Gal4
transactivation domain are shown schematically on the left and indicated by amino acid numbers. The closed box represents the T1 homology region. The respective
reporter β-gal activities expressed in units are shown on the right. (B and C) The mean and standard deviation are presented for at least 4 assays performed with
independent transformants.
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due to improper expression or folding of the corresponding
Gal4-Rep fusion proteins. In summary, interaction with KCTD5
requires both the Rep68 N-terminus constituting part of the
DNA binding domain and the region surrounding the Rep68
nuclear localization signal.
In KCTD5, the first 20 amino acids were clearly dispen-
sable for interaction with Rep68 as demonstrated by the
identification of a clone missing these sequences in the initialscreening. Further 27 N-terminal amino acids could be
deleted without a decrease in the strength of interaction
(Fig. 2C). In contrast, interaction clearly involved the region
homologous to the T1 tetramerization domain (TD), since
already deletion of minor parts of this region led to an almost
complete abrogation of reporter gene activation (Fig. 2C,
KCTD5-N3). In addition to the TD homology region,
C-terminal KCTD5 sequences were also required (Fig. 2C,
compare KCTD5-C1 and KCTD5-C2).
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Since no data had been published yet regarding possible
functions of KCTD5, we first determined its subcellular locali-
zation in HeLa cells through expression of a fusion protein with
the yellow fluorescent protein (YFP-KCTD5). Whereas cells
expressing YFP alone displayed a diffuse cellular fluorescence
both in the nucleus and the cytoplasm (Fig. 3A), the fluores-
cence of YFP-KCTD5 was restricted almost exclusively to the
cytoplasm (Fig. 3B). To exclude the possibility that the YFP-
KCTD5 fusion protein was excluded from the nucleus due to its
size, which was determined to be about 53 kDa by immunoblot
analysis after SDS-PAGE (Fig. 3D), we additionally performed
immunofluorescence analysis with a KCTD5 protein harboring
at its N-terminus the small FLAG-tag epitope. A predominantly
cytoplasmic staining pattern was also observed for this proteinFig. 3. Subcellular localization of exogenous KCTD5 proteins. HeLa cells were
transfected with expression constructs for YFP, an YFP-KCTD5 fusion protein
or a FLAG-tagged KCTD5 protein as indicated. (A and B) Subcellular locali-
zation of YFP and YFP-KCTD5 was determined by direct fluorescence micro-
scope analysis. (C) Immunofluorescence analysis of FLAG-tagged KCTD5 with
the monoclonal anti-FLAG antibody M2 and a secondary anti-mouse Alexa 594
antibody. (D) Expression levels of YFP and different amounts of transfected
YFP-KCTD5 as determined by western analysis with a polyclonal anti-GFP
antibody. (E) Western analysis of different amount of transfected FLAG-KCTD5
with the monoclonal anti-FLAG antibody M2.(Fig. 3C), which has a size of only 28 kDa (Fig. 3E). Thus,
KCTD5 appears to be specifically retained in the cytoplasm.
The large Rep proteins and KCTD5 form complexes in
mammalian cells
To confirm the interaction between the large Rep proteins
and KCTD5 in mammalian cells, we performed coimmunopre-
cipitation experiments after cotransfection of HeLa cells with an
expression construct for a FLAG-tagged KCTD5 protein
harboring amino acids 21 to 234 (KCTD5-N1) and different
Rep expression plasmids. When Rep78 or Rep68 was cotrans-
fected with KCTD5-N1, the FLAG-tagged KCTD5 protein
could clearly be detected in the Rep immunoprecipitates (Fig.
4A, upper panel). Control experiments performed in the absence
of KCTD5 clearly showed that these signals were not due to a
cross-reaction of the anti-FLAG antibody with other cellular
proteins or Rep degradation products (not shown). In line with
the yeast-two-hybrid data, FLAG-KCTD5-N1 was only barely
detectable in Rep immunoprecipitates from cells transfected
with the M172/530 mutant and not detectable in Rep40
immunoprecipitates (Fig. 4A, lanes 4 and 5). Of note, the
amounts of M172/530 and Rep40 proteins precipitated with the
Rep antiserum were comparable to those of Rep78 and Rep68
(Fig. 4A, middle panel). Identical amounts of FLAG-KCTD5-
N1 were detected in whole cell extracts of all transfections (Fig.
4A, lower panel). Therefore, KCTD5 exclusively and specifi-
cally coprecipitates with the large Rep proteins.
The requirement for the region covering the NLS of the large
Rep proteins found in the yeast two-hybrid interaction studies
could be confirmed in coimmunoprecipitation experiments.
Whereas KCTD5 could be coprecipitated with the M1/530 and
M1/514 Rep mutants, no KCTD5 was detected in immuno-
precipitates of M1/481, the Rep mutant missing the amino
acids 482 to 514 (Fig. 4B, upper panel). Control immunoblots
showed that similar amounts of Rep proteins were precipi-
tated (Fig. 4B, middle panel) and KCTD5 protein expression
levels were unchanged (Fig. 4B, lower panel).
In the experiments described so far, the Rep proteins were
highly expressed under the control of the heterologous human
cytomegalovirus promoter (HCMV). To demonstrate Rep-
KCTD5 complex formation under moderate Rep expression
levels, a plasmid harboring the complete AAV-2 genome was
cotransfected with increasing amounts of the FLAG-KCTD5-
N1 expression construct. Expression of all four Rep proteins
from their cognate promoters was induced by infection with
adenovirus type 2 (Fig. 5, middle panel). Again, KCTD5 could
be detected specifically in the Rep immunoprecipitates (Fig. 5,
upper panel), even at the lowest KCTD5 concentration (Fig. 5,
lane 3), which was barely detectable in whole cell extracts (Fig.
5, lower panel).
The large Rep proteins induce the translocation of KCTD5 into
the nucleus
The large Rep proteins have been shown to be located
predominantly in the nucleus, both after transfection and upon
Fig. 4. Coprecipitation of Rep proteins and KCTD5 in mammalian cells. (A and B) HeLa cells were cotransfected with FLAG-tagged KCTD5-N1 (KCTD5 amino
acids 21 to 234) and the indicated Rep expression constructs. Cell extracts prepared with RAF buffer were subjected to immunoprecipitation with a polyclonal anti-Rep
antiserum and precipitated proteins were analyzed by immunoblotting with the monoclonal Rep antibody 303.9 (middle panels) or the monoclonal anti-FLAG
antibody M2 recognizing the coprecipitated FLAG-KCTD5-N1 (upper panels). In parallel, whole cell extracts were analyzed for FLAG-KCTD5-N1 expression levels
with the FLAG M2 antibody (lower panels). Positions of Rep proteins and FLAG-KCTD5-N1 are indicated by arrows, while the positions of immunoglobulin heavy
chains of the antibodies used for precipitation are indicated both by arrows and asterisks. (A) Coprecipitation of KCTD5 with Rep78 and Rep68. (B) Coprecipitation of
KCTD5 with C-terminal Rep deletion mutants.
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complex formation between the large Rep proteins and KCTD5
in human cells, we next asked whether the expression of the
large Rep proteins would lead to an altered subcellular location
of the KCTD5 protein. Immunofluorescence analysis showed
that, in the absence of Rep protein expression, KCTD5 was
located almost exclusively in the cytoplasm (Fig. 6A, also
compare Fig. 3C). Upon Rep78 expression, KCTD5 was now
found predominantly in the nucleus (Fig. 6C), where it showed
a homogenous distribution pattern with exclusion of the
nucleoli similar to that of Rep78 (Figs. 6C to E). Thus,
Rep78/KCTD5 complex formation induces the accumulation of
KCTD5 in the nucleus. A similar translocation of KCTD5 was
observed after cotransfection of Rep68, but not after cotransfec-
tion of the corresponding small Rep protein Rep40 (data not
shown).
Nuclear localization of the large Rep proteins is not required
for interaction with KCTD5
The region between Rep78/Rep68 amino acids 482 to 514,
which was required for interaction with KCTD5 both in thetwo-hybrid system and in the coprecipitation studies, contains
two stretches of basic amino acids. These constitute a bipartite
NLS that mediates interaction with the nuclear import receptor
importin α (Cassell and Weitzman, 2004). However, Rep
deletion mutants missing this region have been shown to be
impaired for additional properties of the large Rep proteins
such as DNA binding in vitro (Yang et al., 1992; Yang and
Trempe, 1993). Thus the lack of KCTD5 binding observed for
the Rep deletion mutant M1/481 was not necessarily linked to
the absence of the NLS. To elucidate whether nuclear
accumulation of the large Rep proteins was required for
formation of stable Rep/KCTD5 complexes, we generated
Rep78 and Rep68 mutants with point mutations in the basic
residues of the NLS according to Cassell and Weitzman
(2004). In line with the results of Cassell et al., we observed a
predominantly cytoplasmic staining for the Rep NLS point
mutants (Figs. 7C and E, Rep78-NLSp and Rep68-NLSp),
whereas the corresponding wildtype proteins were located in
the nucleus (Figs. 7B and D). In the coimmunoprecipitation
analysis, the Rep NLS point mutants coprecipitated similar
amounts of KCTD5 as the wildtype proteins (Fig. 7A, upper
panel, compare lane 4 with lane 3 and lane 6 with lane 5,
Fig. 5. Rep/KCTD5 coprecipitation after transfection with an infectious AAV
genome and overinfection with adenovirus. HeLa cells were cotransfected with
constant amounts (2 μg) of plasmid pTAV2-0 harboring the complete AAV
genome and increasing amount of FLAG-tagged KCTD5-N1 expression
construct as indicated. 16 h posttransfection cells were infected with adenovirus
type 2 (MOI=10). 24 h post-infection Rep immunoprecipitations were per-
formed essentially as described in the legend to Fig. 4 and analyzed for KCTD5
by immunoblotting with the monoclonal anti-FLAG antibody M2 (upper panel).
In parallel, whole cell extracts were analyzed for Rep expression levels with the
monoclonal Rep antibody 303.9 (middle panel) and for KCTD5 expression
levels with the FLAG M2 antibody (lower panel). Positions of Rep proteins,
FLAG-KCTD5-N1 and immunoglobulin heavy chains of the antibodies used for
precipitation are indicated by arrows.
Fig. 6. Translocation of KCTD5 into the nucleus after Rep coexpression. HeLa was c
expression vector pCATCH, (B) pKEX-Rep78 and pCATCH), or (C to E) both pCA
immunofluorescence analysis with a mixture of the monoclonal anti-FLAG antibo
secondary anti-mouse FITC and anti-rabbit TRITC antibodies. (E) Shows a merged
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point mutants were not able to induce the nuclear accumulation
of KCTD5, as no significant alterations in the subcellular
distribution of KCTD5 or the Rep mutants were found after
coexpression of both proteins (data not shown). These results
strongly suggest that complex formation between the wildtype
Rep proteins and KCTD5 is not restricted to the nucleus, but
also takes place in the cytoplasm.
The C-terminal region of KCTD5 required for interaction with
the large Rep proteins blocks nuclear accumulation of KCTD5
In the yeast-two hybrid system, the N-terminal KCTD5
sequences upstream of the TD (T1 tetramerization domain)
homology region could be deleted without a loss of interaction
with the large Rep proteins, while deletion of the KCTD5 C-
terminus (amino acids 204 to 234) abolished interaction
(compare Fig. 2C, KCTD5-N2 and KCTD5-C2). These results
could also be confirmed in the mammalian cell system, as the
KCTD5-N2 mutant, but not the C-terminal C2 deletion mutant
was coprecipitated with Rep68 (Fig. 8B). Similar to the
wildtype protein, the N2 mutant also displayed a predominantly
cytoplasmic staining in the absence of Rep protein expression
(Fig. 8C) and was translocated into the nucleus in the presence
of either Rep78 (Figs. 8E to G) or Rep68 (data not shown).
Unexpectedly, the C2 mutant negative for Rep interaction was
located almost exclusively in the nucleus already in the absence
of Rep protein expression. In western blot analysis, KCTD5-C2
gave rise to a band migrating at the expected size of 23 kDa and
an additional strong band of 45 kDa (Fig. 8A). This 45 kDa
band appears to be due to the formation of a very stable KCTD-
C2 dimer, a view, which is supported by the appearance of a
series of even larger bands in the immunoblot.otransfected with equal amounts (2 μg) of (A) pCATCH-KCTD5 and the empty
TCH-KCTD5 and pKEX-Rep78. 40 h posttransfection, cells were subjected to
dy M2 and a polyclonal Rep antiserum from rabbit followed by a mixture of
image of (C and D).
Fig. 7. Interaction between the large Rep proteins and KCTD5 does not require the Rep NLS. (A) HeLa cells were cotransfected with FLAG-KCTD5-N1 and the
indicated Rep expression constructs. Cell extracts prepared with RAF buffer were subjected to immunoprecipitation with a polyclonal anti-Rep antiserum and
precipitated proteins were analyzed by immunoblotting with the monoclonal anti-FLAG antibody M2 (upper panels) or the monoclonal Rep antibody 303.9 (middle
panels). In parallel, whole cell extracts were analyzed for FLAG-KCTD5 expression levels with the FLAGM2 antibody (lower panels). (B to E) HeLa cells expressing
wildtype Rep78, Rep78-NLSp) point mutant, wildtype Rep68 or Rep68-NLSp point mutant as indicated were fixed and subjected to immunofluorescence staining
with (B and C) the anti-Rep mAb 76.3 and an anti-mouse IgG Alexa 594 conjugated secondary antibody for the detection of Rep78 proteins or (D and E) a polyclonal
Rep antiserum from rabbit followed by secondary anti-rabbit TRITC antibody for the detection of Rep68 proteins.
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To obtain clues to a possible function of KCTD5 in the
AAV-2 life cycle, we examined mRNA expression levels in
HeLa cells after infection with the helper adenovirus type 2,
after infection with AAV-2 only and after AAV-2/adenovirus
type coinfection. We observed a strong down-regulation of
the 2.4 kb KCTD5 mRNA 40 h post-infection with
adenovirus (Fig. 9A, lane 2), which was partially relieved
by coinfection with AAV-2 (Fig. 9A, lane 4). In contrast,
AAV-2 infection alone had no major effect on KCTD5
expression levels (Fig. 9A, lane 3). From this result, we
hypothesized that KCTD5 might function as an endogenous
inhibitor of AAV-replication. However, when we cotrans-
fected KCTD5 together with an infectious AAV plasmid in
the presence of adenovirus, neither AAV DNA replication nor
AAV gene expression at the level of Rep and Cap proteins
was influenced substantially with increasing concentrations of
the KCTD5 expression plasmid (Figs. 9B to D). In line with
these data, KCTD5 overexpression also did not have a major
impact on the formation of infectious AAV particles (not
shown).KCTD5 suppresses posttranscriptional Rep68-mediated
reporter gene activation
Since regulation of AAV gene expression in the presence of
helpervirus is subject to complex regulatory mechanisms in the
nucleus and probably also in the cytoplasm, we turned to a
regulatory effect of the large Rep proteins on heterologous gene
expression assumed to be primarily exerted in the nucleus. The
large Rep proteins have been shown to inhibit several cellular
and viral promoters (Antoni et al., 1991; Hermonat, 1994; Horer
et al., 1995; Labow et al., 1987) including the long terminal
repeat region of the human immunodeficiency virus type 1 (HIV-
LTR). Reporter assays with theβ-globin gene, which generates a
very stable messenger, suggested that the inhibition of the HIV-
LTR takes place at the transcriptional level (Horer et al., 1995).
Rep78 and Rep68 clearly differed in their capacity to down-
regulate the HIV-LTR and also other heterologous promoters.
Whereas Rep78 generally showed a strong inhibition, only
modest effects were observed for Rep68. Surprisingly, when we
monitored the influence of Rep68 on HIV-LTR driven reporter
gene expression at the protein level with luciferase as a reporter
gene, we observed a 10-fold increase in luciferase activity (Fig.
Fig. 8. A C-terminal KCTD5 deletion mutant is located in the nucleus. HeLa was cotransfected with either 2 μg FLAG-KCTD5 expression constructs plus 2 μg of the
empty vector pCATCH, or 2 μg FLAG-KCTD5 expression constructs plus 2 μg of Rep expression plasmids as indicated. (A) Whole cell extracts were analyzed for
FLAG-KCTD5 expression with the FLAGM2 antibody. (B) Cell extracts prepared with RAF buffer were subjected to immunoprecipitation with a polyclonal anti-Rep
antiserum and precipitated proteins were analyzed by immunoblotting with the monoclonal anti-FLAG antibody M2. (C to G) In parallel, cells were subjected to
immunofluorescence analysis with a mixture of the monoclonal anti-FLAG antibody M2 and a polyclonal Rep antiserum from rabbit followed by a mixture of
secondary anti-mouse FITC and anti-rabbit TRITC antibodies. (G) shows a merged image of (E and F).
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transcriptional level, as virtually no changes in the level of the
luciferase mRNA isolated in parallel were observed (Fig. 10B).
Since KCTD5 seems to be able to interact with Rep68 in the
cytoplasm, we then analyzed, how this Rep68-mediated acti-
vation of HIV-LTR driven luciferase reporter gene would be
influenced by overexpression of KCTD5. Whereas KCTD5 had
no effect on luciferase reporter gene expression, when expressed
in the absence of Rep68, it completely abrogated Rep68-
mediated activation (Fig. 10A). Even a modest inhibition of
luciferase activity was seen after Rep68/KCTD5 coexpression.
In contrast, no major activation or inhibition could be observed
at the luciferase mRNA level (Fig. 10B), which demonstrates
that these effects are not exerted at the level of transcription.
Similar results were also obtained, when β-galactosidase instead
of luciferase was used as a reporter to monitor HIV-LTR driven
gene expression (data not shown).
Discussion
The large Rep proteins Rep78 and Rep68 of AAV-2 are
essential for AAV DNA replication and the regulation of AAV
gene expression both in the presence and absence of helpervirus
(Berns, 1990; Carter et al., 1990). The multitude of functionsassociated with these proteins demands that, in addition to their
intrinsic activities such as helicase or sequence-specific
endonuclease, they should be able to recruit a large number of
cellular factors involved in the AAV life cycle. Most of the
Rep78/Rep68 interacting proteins identified so far are located in
the nucleus and appear to be involved either in AAV DNA
replication or play a role in transcriptional regulation. These
Rep interaction partners include the high mobility chromosomal
protein HMG1 (Costello et al., 1997), the transcription factor
Sp1 (Pereira and Muzyczka, 1997b), the TATA box binding
protein (TBP) (Hermonat et al., 1998; Needham et al., 2006),
the transcriptional coactivator PC4 (Weger et al., 1999),
ANP32B as a member of the template-activating factor I/Set
oncoprotein (TAF-I/Set) (Pegoraro et al., 2006) and the protein
kinases X (PKX) and A (PKA) (Chiorini et al., 1998; Di
Pasquale and Chiorini, 2003). More recently, the nucleolar B23/
Nucleophosmin (NPM) protein, which, based its localization,
may affect AAV virion assembly, has also been identified as a
Rep interaction partner (Bevington et al., 2007).
In contrast to these previously described Rep interaction
partners, the KCTD5 protein is located mainly in the cytoplasm,
at least in the absence of Rep expression. At first glance it thus
seems to be a rather unusual interaction partner for the large Rep
proteins, which are located mainly in the nucleus. Complex
Fig. 9. Down-regulation of KCTD5 mRNA after adenovirus infection and impact of KCTD5 overexpression on AAV DNA replication and gene expression. (A) HeLa
cells were mock-infected, infected with adenovirus type 2 (MOI=10) or AAV-2 (MOI=10), or coinfected with both adenovirus and AAV-2 (MOI=10 for both viruses)
as indicated. At 40 h post-infections, cells were assayed for KCTD5 mRNA levels by Northern blot analysis. A control hybridization with a β-actin probe revealed
equal amounts of RNA in all lanes (not shown). (B to D) HeLa cells were cotransfected with constant amounts (2 μg) of plasmid pTAV2-0 harboring the complete AAV
genome and increasing amount of FLAG-tagged KCTD5 expression construct as indicated. Cells were overinfected with adenovirus type 2 at an MOI of 10. At 24 h
post-infection, they were monitored (B) for AAV DNA replication by southern blot analysis and (C) for Rep or (D) Cap expression by immunoblot analysis with
monoclonal antibodies 303.9 or B1, respectively. (B) Positions of monomeric (RF-M) and dimeric replicative (RF-D) as well as single-stranded AAV-DNA (ssDNA)
are indicated by arrows. (C and D) Positions of Rep protein and Capsid proteins are also indicated by arrows.
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not only demonstrated in the yeast-two system, where the
proteins of interest are tethered to the nucleus through the DNA
binding domain or the transactivation domain of the Gal4 trans-
cription factor, but also clearly takes place in mammalian cells
with the native proteins. The coprecipitation of Rep and KCTD5
in HeLa cells was not restricted to high-level expression of both
proteins from the strong heterologous CMV promoter, but was
also observed after expression of the Rep proteins in their natural
context from the AAV-2 p5 promoter in the presence of
adenovirus as a helpervirus. Furthermore, Rep/KCTD5 complex
formation results in the accumulation of KCTD5 in the nucleus.
However, the Rep/KCTD5 interaction is not restricted to the
nuclear fractions of KCTD5 or the Rep proteins, since Rep78/
Rep68 NLS point mutants largely retained in the cytoplasm
coprecipitated KCTD5 in similar amounts as the wildtype Rep
proteins. Thus, KCTD5 represents a potential regulator of the
AAV life cycle both in the nucleus and the cytoplasm.
The mutational analysis of the Rep domains required for
binding of KCTD5 suggested a role of KCTD5 as a positive
cofactor for the nuclear functions of the large Rep proteins.
These functions include the promotion of AAVDNA replication
and regulation of AAV gene expression at the transcriptional
level and require both the N-terminal Rep DNA binding domain(Cathomen et al., 2000; Owens et al., 1993) and the region
between Rep amino acids 482 and 514 (Yang et al., 1992; Yang
and Trempe, 1993), which were also found to be involved in
Rep/KCTD5 interaction. On the other side, the strong down-
regulation of endogenous KCTD5 mRNA observed in HeLa
cells after infection with adenovirus, a helper for productive
AAV replication, rather pointed to an inhibitory function of
KCTD5. As stated in the Results section, the analysis of AAV
DNA replication and AAV gene expression in the presence of
adenovirus after overexpression of KCTD5 did not conclusively
support either possibility. However, due to the complex pattern
of interactions between functions of the helpervirus, the large
Rep proteins and cis-regulatory elements in the AAV genome,
which govern AAV replication (Li et al., 1997; Pereira et al.,
1997; Pereira and Muzyczka, 1997a; Weger et al., 1997), an
involvement of KCTD5 in nuclear regulation of AAV
replication clearly should not be excluded.
Although enzymatically active Rep68 could be isolated from
cytoplasmic extracts of cells coinfected with AAV and
adenovirus (Im and Muzyczka, 1990, 1992), not much is
known yet about possible functions of this cytoplasmic fraction
of Rep68. To identify functional interactions between KCTD5
and Rep68 in the cytoplasm, we examined the influence of
KCTD5 overexpression on posttranscriptional effects of the
Fig. 10. Rep-mediated posttranscriptional activation of a HIV-LTR luciferase
reporter gene is abrogated by KCTD5. HeLa cells were cotransfected with
constant amounts (2 μg) of a HIV-LTR-Luciferase reporter construct (pHIV-
LTRL) and the respective effector plasmids as indicated. For the KCTD5 and
Rep68 expression plasmids, 1 μg of DNA's was transfected. All transfections
were adjusted to a total DNA amount of 4 μg by addition of the empty
expression vector pCATCH. In the negative control, the HIV-LTR reporter
construct was omitted. At 36 h posttransfection, cells were assayed for (A)
luciferase activity levels corrected for protein concentrations and (B) for
luciferase RNA steady-state levels by light-cycler based quantitative RNA
analysis. Both protein activity and RNA levels are expressed as relative values
with the control transfection containing only the HIV-LTR-Luciferase reporter
construct and the empty pCATCH vector set as 1.
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activation of a luciferase reporter gene expressed from the HIV-
LTR. This activation was accompanied by only minor changes
in luciferase mRNA levels strongly arguing that it takes place at
the level of translation. These results seem to be contradictory to
those of Takeuchi et al. (2000), who had reported on a Rep78-
mediated suppression of translation of a luciferase reporter gene
driven by the CMV promoter. However, the primary luciferase
mRNA transcripts generated in the two systems differ vastly,
both in their 5'-nontranslated and the coding region, and these
differences may be responsible for the divergent findings. The
major point to be emphasized is that overexpression of KCTD5
completely abrogated the Rep68-mediated posttranscriptional
activation of luciferase gene expression, strongly arguing for a
functional cross-talk between the two proteins in the cytoplasm.What remains to be explored in the future is the mechanism, by
which KCTD5 blocks Rep68-mediated translational activation.
One possibility is that activation requires Rep oligomerization,
which in turn might be inhibited by Rep/KCTD5 complex
formation. Another important question to be addressed is to
what extent interactions between the large Rep proteins and
KCTD5 in the cytoplasm may be involved in the regulation of
AAV gene expression. Almost no information is available yet
on Rep-mediated posttranscriptional regulation of Rep and Cap
protein expression. In one study involving a p40-CAT reporter
construct, a Rep-mediated inhibition of CAT protein expression
despite increased levels of p40-CAT-mRNA was observed in
293 cells in the absence of helper virus (Trempe and Carter,
1988). Posttranscriptional regulation of AAV gene expression is
also subject to functions of the helper virus such as the E1B-55
kDa and E4-34 kDa proteins of adenovirus type 2 (Samulski
and Shenk, 1988), again creating a very complex pattern of
possible interactions between the KCTD5 protein, the AAV Rep
proteins and helper genes. Studies planned for the future will
address the question of a possible involvement of KCTD5 in the
regulation of AAV gene expression by a functional knockdown
of endogenous KCTD5 expression.
As mentioned before, despite the predominantly nuclear
localization of the large Rep proteins (Horer et al., 1995; Hunter
and Samulski, 1992; Im and Muzyczka, 1992), purification of
functional Rep68 has been achieved from a cytoplasmic cell
extract after coinfection with AAVand adenovirus. Moreover, a
recent study with the same Rep NLS point mutants that were
used in our experiments suggested that the Rep proteins might be
capable of shuttling between the cytoplasm and the nucleus
(Cassell andWeitzman, 2004). As observed earlier for the related
nonstructural protein NS1 of the autonomous parvovirus MVM
(Nuesch and Tattersall, 1993), the Rep NLS mutants could be
transported into the nucleus by the wildtype proteins (Cassell
and Weitzman, 2004). So obviously these proteins associate in
the cytoplasm before they are transported into the nucleus. In a
similar fashion, association of the large Rep proteins with
KCTD5 in the cytoplasm may lead to the shuttling of the Rep/
KCTD5 complex into the nucleus. This possibility is strongly
supported by the stable interaction observed between KCTD5
and the Rep NLS point mutants. However, based on some of our
data, an alternative mechanism for the Rep-mediated accumula-
tion of KCTD5 in the nucleus can be envisioned. The KCTD5
protein also seems to be subject to nuclear-cytoplasmic shuttling,
since a KCTD5 deletion mutant missing the C-terminal domain
required for Rep interaction was located predominantly in the
nucleus already in the absence of Rep protein expression. Thus,
it is tempting to speculate that the C-terminal KCTD5 region
contains a nuclear export signal (NES) involved in the cyto-
plasmic accumulation of KCTD5. Interaction of the large Rep
proteins with this domain could mask the NES leading to a
nuclear retention of KCTD5. Such a mechanism has been shown
to be involved in the regulation of the subcellular localization of
a variety of cellular proteins including the breast cancer-asso-
ciated proteins BRCA1 and BARD1 (Fabbro et al., 2002; Fabbro
et al., 2004; Rodriguez et al., 2004). In this second scenario,
complex formation of Rep with the nuclear fraction of KCTD5
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KCTD5. Of course, both mechanisms, enhanced import into the
nucleus or reduced export of KCTD5 into the cytoplasm, are not
mutually exclusive. With regard to future studies, the C-terminal
KCTD5 deletion mutant seems to represent a suitable tool to
elucidate the nuclear functions of KCTD5.
Methods
Plasmids
The majority of the pGBT9 based yeast two-hybrid ex-
pression constructs encoding fusions of the Gal4 DNA-binding
domain with various parts of the Rep open reading frame have
been described before (Weger et al., 2002, 2004, 1999).
Plasmids pGBT9-M1/530 and pGBT9-M1/514 were obtained
by replacing the NotI/XbaI Rep fragment in pGBT9-Rep68
with the corresponding fragments from pKEXStop531 and
pKEXStop515 (Horer et al., 1995), respectively. Plasmids
pACT2-KCTD5 and pACT2-KCTD5-N1 encoding fusions of
the complete open reading frame of KCTD5 (amino acids 1 to
234) or KCTD5 amino acids 21 to 234, respectively, with the
Gal4 transactivation domain correspond to two of the original
clones obtained in the yeast two-hybrid screen for Rep68
interacting proteins in 293 cells. All other KCTD5 two-hybrid
constructs were obtained from pACT2-KCTD5-N1 through
PCR based amplification of the indicated parts of the KCTD5
coding region and subcloning into EcoRI/XhoI digested pACT2
vector (restriction sites in the PCR fragments for cloning were
generated by the PCR primers).
The pKEX-Rep constructs expressing Rep78, Rep68 or
Rep40 under the control of the human cytomegalovirus early
promoter have been described (Horer et al., 1995). The pKEX-
Rep deletion mutant M172, which contains Rep amino acids
172 to 621, has also been described (Kleinschmidt et al., 1995).
The pKEX-Rep78-NLSp and pKEX-Rep68-NLSp constructs
harboring point mutations in the basic residues of the Rep
nuclear localization signal were generated according to Cassell
and Weitzman (2004) by site-directed mutagenesis (Quik-
Change Site-Directed Mutagenesis Kit, Stratagene). Plasmids
pCATCH-KCTD5, pCATCH-KCTD5-N1, pCATCH-KCTD5-
N2 and pCATCH-KCTD-C2 were generated by subcloning of
KCTD5 restriction fragments from the corresponding pACT2
constructs into the eukaryotic FLAG-tag expression vector
pCATCH (Georgiev et al., 1996) using the following restriction
enzymes: SalI/XbaI for the full-length KCTD5; EcoRI/XbaI for
KCTD5-N1; EcoRI/XhoI for KCTD5-N2 and KCTD5-C2.
For construct pYFP-KCTD5, the complete KCTD5 open
reading frame was excised from pCATCH-KCTD5 with EcoRI
and XbaI and subcloned into EcoRI/XbaI digested pEYFP-C2
(Clontech).
For plasmid pHIV-LTRL, the 3'-LTR of the human immu-
nodeficiency virus type 1 (HIV-1) was excised as a BamHI/
HindIII fragment (nucleotides 8455 to 9610) from PNL4-3
(Adachi et al., 1986) and subcloned into BamHI/HindIII linear-
ized vector pBL (de Wet et al., 1987) encoding the luciferase
reporter gene.All the expression vectors generated by PCR based cloning
or by site-directed mutagenesis were sequenced to confirm that
the inserted or mutated sequences were correct.
Yeast two-hybrid screening and analysis
A Gal4 based yeast two-hybrid screening system (Clontech)
was used to isolate cDNAs, which encode proteins that are able
to interact with the AAV-2 large Rep68 protein. Yeast two-
hybrid screening of a cDNA library from noninfected 293 cells
(an E1A/E1B transformed primary embryonic kidney cell line;
ATCC #CRL1573) in vector pACT2 (cDNA library obtained
from Clontech) was performed essentially as described in
Weger et al. (1999). Quantitative studies of Rep/KCTD5 two-
hybrid interactions were performed in yeast strain SFY526
(Clontech) as described by Weger et al. (2003).
Cell culture, virus infection and transfection
HeLa cells were propagated in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% fetal calf serum,
100 μg/ml of penicillin and streptomycin, and 2 mM glutamine
at 37 °C and 5% CO2. For virus infection, cells were grown to
60% confluence. Medium was removed and cells were
incubated with either AAV-2 or adenovirus type 2 at MOI's
of 10, or a mixture of both viruses with the same MOI, for 1 h in
a total volume of 400 μl (6 cm dishes) or 1 ml (10 cm dishes).
After the incubation period, DMEM was added to a final
volume of 10 ml and cells were incubated for 40 h. For
transfections, 4×105 (6 cm dishes) or 1.2×106 (10 cm dishes)
cells were transfected by the calcium phosphate precipitate
technique for 16 h at 37 °C and 5% CO2. Medium was replaced
with fresh medium and cells were incubated for a further 24 h
period at 37 °C and 5% CO2. For overinfection with adenovirus,
transfected cells were incubated directly after medium replace-
ment with adenovirus type 2 (MOI=10) as described above and
also incubated for further 24 h.
Immunoprecipitation and western blot analysis
For immunoprecipitation analysis, HeLa cells were washed
two times with PBS and lysed directly in the culture dishes with
1 ml RAF buffer (20 mM Tris–HCl pH 8.0, 137 mMNaCl, 10%
glycerol and 1% NP40) at 4 °C for 10 min. Lysates were
clarified by 15 min centrifugation at 20,800×g and 4 °C. The
supernatant was incubated sequentially with 1 μl of a polyclonal
anti-Rep antiserum from guinea pig for 2 h at 4 °C and 30 μl
Protein A Sepharose beads in RAF buffer (10%, w/v) for 1 h at
4 °C. Beads were washed 5 times with RAF buffer, boiled for
5 min in 40 μl protein sample buffer (1 mM EDTA, 50 mM Tris
pH 7.5, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.01%
bromphenolblue) and 15 μl samples were loaded on poly-
acrylamide gels in the presence of sodium dodecyl sulfate
(SDS-PAGE). For direct analysis of whole cell extracts, 5×105
to 1×106 cells were directly lysed in cell culture dishes by the
addition of 200 μl of protein sample buffer, boiled for 5 min and
subjected to Western blot analysis as described above.
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clonal antibody M2 (Sigma), anti-GFP polyclonal rabbit
antibody FL (Santa Cruz), anti-Rep monoclonal antibody
303.9 (Progen) and anti-Cap monoclonal antibody B1 (Progen).
Immunofluorescence analysis
HeLa cells were grown on coverslips and transfected as
described above. Cells were fixed in 3.7% formaldehyde in PBS
pH 7.4 for 30 min. For direct analysis of fluorescent proteins,
cover slips were then washed two times with PBS. For
additional immunofluorescence analysis, cells were permeabi-
lized for 10 min in 1% Triton X-100 in PBS. Coverslips were
washed twice in PBS and cells were reacted for 60 min with
primary antibodies. After three washes in PBS, cells were
reacted for 45 min with secondary antibodies. The following
combinations of primary and secondary antibodies were used:
monoclonal anti-FLAGM2 in a dilution of 1:400 (all antibodies
were diluted in 2% FCS/PBS) in combination with anti-mouse
Alexa 594 diluted 1:500 for single analysis of KCTD5;
monoclonal anti-Rep 76.3 (Wistuba et al., 1995) diluted 1:1
in combination with anti-mouse Alexa 594 diluted 1:500 for
single analysis of Rep78; rabbit polyclonal anti-Rep antibody
(kindly provided by J. Trempe) diluted 1:150 in combination
with rhodamine-labeled goat anti-rabbit IgG diluted 1:400 for
single analysis of Rep68; and a mixture of monoclonal anti-
FLAGM2 at a final dilution of 1:400 and rabbit polyclonal anti-
Rep antibody diluted 1:150 in combination with rhodamine-
labeled goat anti-rabbit and fluorescein-labeled goat anti-mouse
IgG, both diluted 1:400, for double immunofluorescence
analysis of Rep and KCTD5. All incubations were performed
at room temperature. Cover slips were washed three times in
PBS and mounted in polyvinyl alcohol (Elvanol) containing 1%
DABCO as anti-fading agent mounted with Elvanol/DABCO.
Image acquisition was performed with a motorized Zeiss
Axiophot2 microscope equipped with a Zeiss 63x/1.4 NA Oil
DIC objective, an 1.0×–2.5× optovar and a Princeton Instru-
ments “Micromax“ cooled (−15 °C) slow scan CCD camera
(Kodak KAF-1400 CCD).
Northern blot analysis
RNA from 3×106 cells in 10 cm dishes was isolated ac-
cording to published protocols (Chomczynski and Sacchi, 1987)
by guanidine isothiocyanate lysis. Equal amounts of RNA,
based on the measurement of optical density at 260 nm, were
electrophoresed on a 1% agarose-formaldehyde gel (50 mM
HEPES, pH 7.8, 1 mM EDTA, 6% formaldehyde) and
transferred to a nylon membrane (Gene Screen™, Du Pont
NEN) by capillary blotting in 25 mM phosphate buffer pH
6.8 overnight. For detection of KCTD5 transcripts, a 2.4 kb
EcoRI/XhoI fragment from pACT2-KCTD5 containing the
complete KCTD5 cDNA was labeled by random priming. The
filters were hybridized in hybridization solution (7% SDS (w/
v), 0.125 M sodium phosphate buffer pH 7.2, 0.25 M NaCl,
1 mM EDTA, 45% (v/v) formamide) at 42 °C for 16 to 30 h.
The filters were washed four times in 2× SSC/0.1% SDS at42 °C for 5 min and subsequently two times with 0.1× SSC/
0.1% SDS at 65 °C for 30 min. Filters were air dried and
autoradiographed at room temperature on Fuji RX films.
Extraction of viral DNA and Southern blotting
Extraction of viral DNA by a modified Hirt procedure and
Southern blotting were performed as described by Weger et al.
(1997). After treatment with DpnI to digest input DNA, the
DpnI resistant replicated AAV-DNAs were detected with a
1.59 kb 32P labeled HincII fragment from plasmid pTAV2-0
harboring a large part of the cap open reading frame.
Quantitative real-time PCR for determination of luciferase
mRNA
RNA was isolated as described above. First-strand cDNA
was synthesized in a 20 μl mixture containing 1 μg of RNA, 1×
Expand reverse transcriptase buffer RT (Roche), 1 mM each of
dATP, dCTP, dGTP and dTTP, reverse primer 5′-ACTGAA-
ATCCCTGGTAATCC-3′ (1 mM), 10 mM DTT and 50 Units of
Expand reverse transcriptase (M-MuLV-RT, Roche) for 45 min
at 42 °C. A real-time light cycler PCR was then performed with
a 5 μl aliquot of a 1:10 dilution of the cDNA reactions in a
final volume of 20 μl and included the LightCycler FastStart
DNA Master SYBR Green I mix (polymerase, buffer, dNTP's,
SYBR Green), 500 nM reverse primer and forward primer 5′-
GCGTTATTTATCGGAGTTGC-3′, and 4 mM MgCl2. Ampli-
fication conditions were 95 °C for 10 min to activate the
polymerase, followed by 45 cycles at 95 °C for 5 s, 60 °C for
4 s and 72 °C for 15 s. Standard curves for luciferase cDNA
were generated using plasmid pHIV-LTR-L and analysis of date
was performed with the LightCycler software according to the
manufacturer's instructions.
Reporter gene assays
4×105 to 2×106 cells were washed twice in phosphate-
buffered saline, scraped in 400 μl Triton lysis buffer (1% [vol/
vol] Triton X-100, 25 mM glycylglycine [pH 7.8], 15 mM
MgSo4, 4 mM EGTA, 1 mM dithiothreitol, 10% [vol/vol]
glycerin), and cell debris was removed by centrifugation.
Quantization of luciferase activity was performed with 50 μl of
supernatant and 20 μl of Bright-Glo luciferase substrate
(Promega) using a Centro LB960 luminometer (Berthold,
Germany). Values were normalized for protein concentrations
determined by the method of Bradford et al. (Bradford, 1976).
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